Literature DB >> 31930061

Lactate dehydrogenase as a prognostic marker of renal transplant recipients with severe community-acquired pneumonia: a 10-year retrospective study.

Ying Su1, Min-Jie Ju1, Jie-Fei Ma1, Guo-Wei Tu1, Hong-Yu He1, Zhun-Yong Gu1, Yuan-Lin Song2, Jing Zhang2, Zhe Luo1,3.   

Abstract

BACKGROUND: Lactate dehydrogenase (LDH) is an easily accessible biological marker that has been associated with several pulmonary disorders. The aim of this study was to investigate the prognostic value of serum LDH in renal transplant recipients with severe community-acquired pneumonia (CAP).
METHODS: A total of 77 renal transplant recipients with severe CAP admitted to the intensive care unit (ICU) were screened for eligibility in this retrospective study. Patient characteristics and laboratory tests, such as LDH on day 1 (LDHday 1) and day 3 (LDHday 3) were recorded. Cox regression models were used to assess the performance of LDH to predict 90-day mortality.
RESULTS: Median LDH level was higher on day 1 in 90-day nonsurvivors (440 U/L, IQR, 362-1,055 U/L) than in survivors (334 U/L, IQR, 265-432 U/L; P<0.001); median LDH level on day 3 in nonsurvivors was 522.5 U/L (IQR, 457.5-1,058.5 U/L) and in survivors 290 U/L (IQR, 223-387.5 U/L; P<0.001). Analysis of LDH kinetics from day 1 to day 3 showed an increase in nonsurvivors and a decrease in survivors. Moreover, Multivariate Cox analysis showed that LDHday 1 (increase per 100 U/L), LDHday 3 (increase per 100 U/L) and LDH kinetics (increase per 10%) were independently associated with 90-day mortality.
CONCLUSIONS: Serum LDH levels and LDH kinetics early were independently associated with 90-day mortality in renal transplant recipients with severe CAP. In future, the prognostic role of LDH needs to be warranted. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Community-acquired pneumonia (CAP); lactate dehydrogenase (LDH); mortality; renal transplantation; severe pneumonia

Year:  2019        PMID: 31930061      PMCID: PMC6944597          DOI: 10.21037/atm.2019.10.75

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  33 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

Review 2.  The clinical value of lactate dehydrogenase in serum: a quantitative review.

Authors:  H J Huijgen; G T Sanders; R W Koster; J Vreeken; P M Bossuyt
Journal:  Eur J Clin Chem Clin Biochem       Date:  1997-08

Review 3.  Community-acquired pneumonia.

Authors:  Daniel M Musher; Anna R Thorner
Journal:  N Engl J Med       Date:  2014-10-23       Impact factor: 91.245

4.  Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality.

Authors:  S Reyes; B Montull; R Martínez; J Córdoba; J M Molina; V Martí; A Martínez; P Ramírez; R Menéndez
Journal:  Respir Med       Date:  2011-05-10       Impact factor: 3.415

5.  Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Aizhen Lu; Chuankai Wang; Xiaobo Zhang; Libo Wang; Liling Qian
Journal:  Respir Care       Date:  2015-06-09       Impact factor: 2.258

6.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

7.  PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

Authors:  Jordi Rello; Alejandro Rodriguez; Thiago Lisboa; Miguel Gallego; Manel Lujan; Richard Wunderink
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

8.  Acute quadriplegia caused by necrotizing myopathy in a renal transplant recipient with severe pneumonia: acute onset and complete recovery.

Authors:  Guo-Wei Tu; Jie-Qiong Song; Simon Kang Seng Ting; Min-Jie Ju; Hong-Yu He; Ji-Hong Dong; Zhe Luo
Journal:  Eur J Med Res       Date:  2015-02-03       Impact factor: 2.175

Review 9.  The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.

Authors:  Javier Carbone
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

10.  The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children.

Authors:  Yuanyuan Zhang; Yunlian Zhou; Shuxian Li; Dehua Yang; Xiling Wu; Zhimin Chen
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more
  7 in total

1.  Preliminary Study on the Combination Effect of Clindamycin and Low Dose Trimethoprim-Sulfamethoxazole on Severe Pneumocystis Pneumonia After Renal Transplantation.

Authors:  Zhun-Yong Gu; Wen-Jun Liu; Dan-Lei Huang; Yu-Jing Liu; Hong-Yu He; Cheng Yang; Yi-Mei Liu; Ming Xu; Rui-Ming Rong; Du-Ming Zhu; Zhe Luo; Min-Jie Ju
Journal:  Front Med (Lausanne)       Date:  2022-05-06

2.  Usage of compromised lung volume in monitoring steroid therapy on severe COVID-19.

Authors:  Ying Su; Ze-Song Qiu; Jun Chen; Min-Jie Ju; Guo-Guang Ma; Jin-Wei He; Shen-Ji Yu; Kai Liu; Fleming Y M Lure; Guo-Wei Tu; Yu-Yao Zhang; Zhe Luo
Journal:  Respir Res       Date:  2022-04-29

3.  Can lactate dehydrogenase (LDH) be used as a marker of severity of pneumonia in patients with renal transplant?

Authors:  Carlos M Luna; María M Perín
Journal:  Ann Transl Med       Date:  2020-08

4.  Comparison of CRB-65 and quick sepsis-related organ failure assessment for predicting the need for intensive respiratory or vasopressor support in patients with COVID-19.

Authors:  Ying Su; Guo-Wei Tu; Min-Jie Ju; Shen-Ji Yu; Ji-Li Zheng; Guo-Guang Ma; Kai Liu; Jie-Fei Ma; Kai-Huan Yu; Yuan Xue; Zhe Luo
Journal:  J Infect       Date:  2020-05-07       Impact factor: 6.072

5.  Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2.

Authors:  Yang Zhou; Ning Ding; Guifang Yang; Wen Peng; Fengning Tang; Cuirong Guo; Xiangping Chai
Journal:  Ann Transl Med       Date:  2020-09

6.  Steroids Therapy in Patients With Severe COVID-19: Association With Decreasing of Pneumonia Fibrotic Tissue Volume.

Authors:  Jin-Wei He; Ying Su; Ze-Song Qiu; Jiang-Jie Wu; Jun Chen; Zhe Luo; Yuyao Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-14

7.  Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.

Authors:  Xingqiang Lai; Zhongpeng Yao; Fen Ning; Lei Zhang; Jiali Fang; Guanghui Li; Lu Xu; Yunyi Xiong; Luhao Liu; Rongxin Chen; Junjie Ma; Zheng Chen
Journal:  Ann Transl Med       Date:  2020-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.